This paper examines the evidence for combining supervised lifestyle modifications with traditional drug therapies to reduce blood pressure in pre-hypertensive and hypertensive adults. Drawing on multiple clinical studies, the paper reviews the limitations of drug therapy alone, the effectiveness of the DASH diet combined with lifestyle counseling, and the role of physician monitoring in patient compliance. It also considers alternative approaches such as relaxation response training and motivational interviewing. The paper concludes that while results in the literature are mixed, monitored intervention strategies show sufficient promise to warrant expanded use and further clinical trials targeting adults with pre-hypertension.
Heart disease is unfortunately one of the most frequent causes of death in the United States. Many Americans suffer from various conditions involving heart disease, including hypertension. For this reason, it is critically important to identify potential problems early and to address them with both strength and effective execution. Understanding how to approach the problem from all sides is crucial within the healthcare field, making it essential to understand how to combine strategies to provide the most effective solution. In pre-hypertensive adults, this includes the combination of traditional therapies with changes in diet and lifestyle. The healthcare field must acknowledge that not everyone will be dedicated to lifestyle changes, and must therefore provide further support through monitored lifestyle modifications — including patient education on self-management of blood pressure — in order to help reduce dangerously high blood pressure levels.
The treatment of high blood pressure in patients with hypertension can vary depending on each individual case. Weber et al. (2009) demonstrated that popular drug treatments, even when used in combination with one another, cannot always be relied upon to lower blood pressure levels to a sufficiently safe level on their own. Weber et al. (2009) conducted a clinical trial working with patients with hypertension who had been slow to respond to traditional treatments alone. The study incorporated 379 patients and used drugs such as a diuretic in the experimental group, with a placebo in the control group. Minor blood pressure reductions were recorded, but side effects included fluid retention and accumulation. The findings suggest that drug therapy alone may not be entirely successful in reducing blood pressure to safe levels compared with when it is combined with dedicated lifestyle modifications.
Another study, Wexler et al. (2009), stated that "physicians often overestimate their effectiveness of the care they provide," often due to a lack of training tools provided to both themselves and their patients (p. 2). Wexler et al. (2009) found that physicians often take a passive role in supervising proposed lifestyle changes and frequently fail to provide clear guidelines that their patients are expected to follow. The data therefore suggests that physicians can inadvertently contribute to patient noncompliance. This raises the question of what additional measures are needed to produce more effective results in promoting healthier lifestyles and appropriate self-management of hypertension. These concerns have prompted the creation of studies that evaluate new control measures to facilitate greater patient awareness through physician monitoring and training.
There is broad agreement in the literature that lifestyle changes — including dietary regulation, physical activity, and weight loss — combined with drug therapies prove more successful than drugs used alone. Cohen et al. (2011) showed that the practice of Iyengar Yoga was effective in helping lower blood pressure levels when compared to a control group. Blumenthal et al. (2010) conducted a study reviewing the impact of combining the DASH (Dietary Approaches to Stop Hypertension) diet with lifestyle modifications in terms of lowering blood pressure in patients. The DASH diet is a strict dietary regulation program that restricts the consumption of various fats while supplementing the diet with low-fat dairy products, vegetables, and fiber-rich foods.
Study participants were recruited from among adults not currently taking antihypertensive medications. Additional eligibility requirements included a minimum age of 35, a BMI between 25 and 40, and a mean systolic blood pressure of 130 to 159 mmHg (Blumenthal et al., 2010). Blood pressure monitoring was conducted through clinic-measured BP, ambulatory BP monitoring, pulse wave velocity, flow-mediated dilation, baroreflex sensitivity, and left ventricular mass index. Nutritional and weight assessments were conducted using self-reported food frequency questionnaires. This was supplemented by enforced interventions during which subjects underwent two-week periods of controlled feeding, representing strict regulation and supervision of dietary habits intended to establish new lifestyle patterns.
Strict adherence to the DASH diet combined with lifestyle changes — often supported by lifestyle counseling — proved to have a significant impact on patient blood pressure levels, far more so than less regulated dietary changes. Conversely, DASH diet restrictions alone, without accompanying lifestyle changes, were less successful, demonstrating the necessity of lifestyle counseling for producing the best outcomes in adult patients with high blood pressure.
"Physician-monitored counseling improves lifestyle change compliance"
"Relaxation training and drug combinations show varied effectiveness"
Dusek, J. A., Hibberd, P. L., Buczynski, B., Chang, B., Dusek, K., Johnston, J. M., Wohlhueter, A. L., Benson, H., & Zusman, R. A. (2008). Stress management vs. lifestyle modification on systolic hypertension and medication elimination: A randomized trial. The Journal of Alternative and Complementary Medicine, 14(2), 129–138.
Navidian, A., Abedi, M. R., Baghban, I., Fateizadeh, M., & Poursharifi, H. (2010). Effect of motivational interviewing on blood pressure of hypertensive patients. Kowsar Medical Journal, 15(2), 115–121.
Smith, S. R., Aronne, L. J., Burns, C. M., Kesty, N. C., Halseth, A. E., & Weyer, C. (2008). Diabetes Care, 31(9), 1816–1823.
Tuomilehto, H. P. I., Seppä, J. M., Partinen, M. M., Peltonen, M., Gylling, H., Tuomilehto, J. O. I., Vanninen, E. J., Kokkarinen, J., Sahlman, J. K., Martikainen, T., Soini, E. J., Randell, J., Tukiainen, H., & Uusitupa, M. (2009). Lifestyle intervention with weight reduction. American Journal of Respiratory and Critical Care Medicine, 179, 320–327.
Weber, M. A., Black, H., Bakris, G., Krum, H., Linas, S., Weiss, R., Linseman, J. V., Warren, M., & Lindholm, L. H. (2009). A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: A randomized, double-blind, placebo-controlled trial. The Lancet, 374(9699), 1423–1431.
Wexler, R., Elton, T., Taylor, C. A., Pleister, A., & Feldman, D. (2009). Physician reported perception in the treatment of high blood pressure does not correspond to practice. BMC Family Practice, 10(23).
You’re 45% through this paper. Sign up to read the remaining 2 sections.
Sign Up Now — Instant Access Already a member? Log inAlways verify citation format against your institution’s current style guide requirements.